<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02801695</url>
  </required_header>
  <id_info>
    <org_study_id>RC15_0475</org_study_id>
    <nct_id>NCT02801695</nct_id>
  </id_info>
  <brief_title>Evaluation of the Efficacy of Citrulline Supplementation on the Delay of Delivery for Women Hospitalized for Pre-eclampsia (CITRUPE)</brief_title>
  <acronym>CITRUPE</acronym>
  <official_title>Evaluation of the Efficacy of Citrulline Supplementation on the Delay of Delivery for Women Hospitalized for Pre-eclampsia (CITRUPE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pre-eclampsia (PE) complicates 2-8 % of pregnancies and is associated with high maternal and
      fetal morbidity and mortality. The early clinical manifestations are the occurrence of a
      maternal blood pressure and proteinuria. Placental dysfunction impairs the nutrient supply to
      the fetus, and may be the cause of an intrauterine growth retardation (IUGR). This is a
      disease that causes prematurity and currently the only known cure is delivery of the
      placenta. Nitrogen monoxide (NO) regulates the placental blood flow. However, pre-eclampsia
      is directly related to a failure of placental NO production. In this context, several
      clinical trials have tested the effect of NO donors such as L- arginine. However,
      supplementation with L -Arginine in a randomized trial in Nantes, has proved to be
      ineffective in severe vascular IUGR.

      Citrulline is a natural aminoacid precursor to arginine and in contrast to L-arginine escapes
      uptake in the liver and appears directly in the peripheral blood converted by the kidney in
      arginine, released into the systemic circulation, Citrulline may therefore be more effective
      in the treatment of pre-eclampsia.

      This prospective, randomized, comparative and double-blinded study aims to prolong pregnancy
      for patients with pre-eclampsia before 36 weeks.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 20, 2017</start_date>
  <completion_date type="Anticipated">October 20, 2018</completion_date>
  <primary_completion_date type="Anticipated">October 20, 2018</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of days between the therapeutic initiation and childbirth</measure>
    <time_frame>childbirth</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">116</enrollment>
  <condition>Pre-eclampsia</condition>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>L-Citrulline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bolus (9g) after patient stabilization, then 3g 3 times a day until delivery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lactose</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Bolus (9g) after patient stabilization, then 3g 3 times a day until delivery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Citrulline</intervention_name>
    <description>Citrulline supplementation</description>
    <arm_group_label>L-Citrulline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Lactose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt;= 18 years old

          -  pregnant woman

          -  singleton pregnancy

          -  woman with pre-eclampsia (&lt;36 weeks) without indication of forthcoming extraction

          -  subjects affiliated with an appropriate social security system

          -  subjects out of context of guardianship

          -  written signed informed consent form

        Exclusion Criteria:

          -  age &lt; 18 years old

          -  isolated hypertension or isolated proteinuria

          -  severe pre-eclampsia with indication of forthcoming extraction in emergency

          -  term pregnancy &gt;= 36 Weeks when diagnosis is done

          -  multiple pregnancy

          -  lactose intolerance

          -  context of guardianship
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nobert Winer, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Nantes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Norbert Winer, Dr</last_name>
    <phone>+332 40 08 31 90</phone>
    <email>nobert.winer@chu-nantes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Guillaume Ducarme, Dr</last_name>
    <phone>+332 51 44 65 70</phone>
    <email>guillaume.ducarme@chd-vendee.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHD Vend√©e</name>
      <address>
        <city>La Roche sur Yon</city>
        <zip>85925</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guillaume Ducarme, Dr</last_name>
      <email>guillaume.ducarme@chd-vendee.fr</email>
    </contact>
    <investigator>
      <last_name>Guillaume Ducarme, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norbert Winer, Dr</last_name>
      <email>nobert.winer@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Norbert Winer, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 3, 2016</study_first_submitted>
  <study_first_submitted_qc>June 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 16, 2016</study_first_posted>
  <last_update_submitted>June 1, 2017</last_update_submitted>
  <last_update_submitted_qc>June 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pre-eclampsia</keyword>
  <keyword>citrulline</keyword>
  <keyword>pregnancy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eclampsia</mesh_term>
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

